These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26445309)

  • 1. International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening.
    Okada T; Tanaka K; Kawachi H; Ito T; Nishikage T; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Karelovic S; Flores S; Estela R; Tsubaki M; Uetake H; Eishi Y; Kawano T
    Cancer; 2016 Jan; 122(1):71-7. PubMed ID: 26445309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic study from a colorectal cancer screening in Chile: results from the first 2 years of an international collaboration between Chile and Japan.
    Kobayashi M; Kawachi H; Pasternak S; Delgado C; Pinto P; Ito T; Karelovic S; Carrasco H; Tanaka K; Okada T; Odagaki T; Zárate AJ; Ponce A; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Eur J Cancer Prev; 2019 Jul; 28(4):245-253. PubMed ID: 29958195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Trial to Quantify Plasma Exosomes in Colorectal Cancer Screening from the International Collaborative Study between Chile and Japan.
    Kobayashi M; Kawachi H; Hurtado C; Wielandt AM; Ponce A; Karelovic S; Pasternak S; Delgado C; Pinto P; Carrasco H; Ito T; Okada T; Tanaka K; Odagaki T; Zárate AJ; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
    Digestion; 2018; 98(4):270-274. PubMed ID: 30130793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer risk factors in asymptomatic Chilean population: a survey of international collaboration between Japan and Chile.
    Okada T; Odagaki T; López-Köstner F; Zárate AJ; Ponce A; Kronberg U; Karelovic S; Flores S; Estela R; Ito T; Yasuno M; Uetake H; Kojima K; Kitagawa M
    Eur J Cancer Prev; 2020 Mar; 29(2):127-133. PubMed ID: 31436751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a multicentric colorectal cancer screening program in Chile].
    López-Kostner F; Zárate AJ; Ponce A; Kronberg U; Kawachi H; Okada T; Tsubaki M; Ito T; Nishikage T; Tanaka K; Kawano T; Eishi Y; Peñaloza P; Estela R; Karelovic S; Flores S
    Rev Med Chil; 2018 Jun; 146(6):685-692. PubMed ID: 30148899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional colorectal cancer screening program using colonoscopy on an island: a prospective Nii-jima study.
    Hotta K; Matsuda T; Kakugawa Y; Ikematsu H; Kobayashi N; Kushima R; Hozawa A; Nakajima T; Sakamoto T; Mori M; Fujii T; Saito Y
    Jpn J Clin Oncol; 2017 Feb; 47(2):118-122. PubMed ID: 28172923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial results of the National Colorectal Cancer Screening Program in Lithuania.
    Poskus T; Strupas K; Mikalauskas S; Bitinaitė D; Kavaliauskas A; Samalavicius NE; Saladzinskas Z
    Eur J Cancer Prev; 2015 Mar; 24(2):76-80. PubMed ID: 25370682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
    Brenner H; Altenhofen L; Stock C; Hoffmeister M
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):717-23. PubMed ID: 25218160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
    Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
    Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.